Category :

Medical Research Press Releases

The Childhood Cancer Project's 100 Keys to the Cure Ultra-Marathon

Caryn Lubetsky, a Miami-based attorney, law professor, mother of three, nationally ranked runner, cross-country coach, two-time Iron-man finisher, ultra runner, childhood cancer advocate and board member of The Childhood Cancer Project, is participating in the 11th annual KEYS100 Mile Individual Ultra-marathon on Saturday and…

ReGenTree Presents Results of a Comparison Study of RGN-259 and Approved Prescription Drugs for Dry Eye Syndrome in a Mouse Model at ARVO

ReGenTree, LLC (the “Company”), a joint venture between GtreeBNT and RegeneRx Biopharmaceuticals, announced today that the Company presented results of a comparison study of RGN-259 and marketed products for dry eye syndrome in a dry eye mouse model at ARVO…

Ethical eAdjudication® Integrates With Guardtime KSI-Blockchain®

Ethical GmbH, the Swiss company providing eClinical Software Services with a special focus on Clinical Endpoint Adjudication, integrates with KSI-Blockchain® to provide a new strong proof-of-evidence for data integrity and time of Audit Trail Records. The Challenge Since the implementation of GxP standards the ALCOA…

Top Enrolling Clinical Site Organization in West Virginia Expands Into CNS/Mental Health Studies

Wilber Z. Sine, MD is joining the top enrolling clinical research team to expand into CNS clinical studies. For over 40 years, Dr. Sine has enjoyed an exemplary career as a professor, medical director in behavioral medicine and psychiatry in…

2,000 Clinical Trial Sites Now Manage eRegulatory for 600 Studies in Florence eBinders

Leading up to the Association of Clinical Research Professionals Annual Meeting in Washington D.C., Florence announced over 2,000 clinical trial teams are now actively managing the eRegulatory and eSource for 600+ Pharmaceutical and Medical Device studies in its eBinders solution. Founded in…

Fortuna Fix Presenting at Unite to Cure: The Fourth International Vatican Conference — How Science, Technology and 21st Century Medicine Will Impact Culture and Society

Fortuna Fix Ltd (“Fortuna”), is a private regenerative medicine company aiming to be the first to bring to the clinic the patients' own (autologous) directly reprogrammed neural precursor cells (“drNPCs”) to replace lost neuronal tissue in neurodegeneration and neurotrauma. On…

Overcoming Bioanalytical Challenges in Drug Discovery and Biomarker Identification, New Webinar Hosted by Xtalks

In this live presentation, featured speakers from KCAS Gene Ray, Ph.D., Senior Scientific Advisor and Lawrence Goodwin, Executive Director of Bioanalytical R&D and LC-MS/MS Services will highlight bioanalytical challenges in drug discovery and some potential solutions. Examples to be presented…

ReGenTree Announces Outcome of FDA Discussions for Development of RGN-259 for Dry Eye Syndrome

ReGenTree Announces Outcome of FDA Discussions for Development of RGN-259 for Dry Eye Syndrome

ReGenTree LLC (the "Company"), a joint venture between GtreeBNT and RegeneRx Biopharmaceuticals, announced today the outcome of discussions with FDA regarding the results of the completed phase 3 clinical trial (ARISE-2) and the future development requirements for a New Drug Application…

Lessons Learned From the Clinical Trial Trenches: How to Use Patient Engagement Technology Successfully, New Webinar Hosted by Xtalks

Lessons Learned From the Clinical Trial Trenches: How to Use Patient Engagement Technology Successfully, New Webinar Hosted by Xtalks

The promises of patient engagement technologies are significant, but can they be kept? It’s possible, but with so many technologies to choose from, implementations that dip into uncharted waters, and limited digital expertise in-house, it can be hard to see…

The Campbell Foundation Awards $100,000 Grant to The Wistar Institute

The Campbell Foundation Awards  $100,000 Grant to The Wistar Institute

The Campbell Foundation, a nonprofit organization dedicated to funding HIV/AIDS research, has awarded a $100,000 grant to Mohamed Abdel-Mohsen, Ph.D., assistant professor in Wistar’s Vaccine & Immunotherapy Center in Philadelphia. Dr. Abdel-Mohsen is studying the role of altered host glycosylation…

St. Catherine's Village to Host Free Seminar on Alzheimer's Disease and Dementia on March 29

St. Catherine's Village to Host Free Seminar on Alzheimer's Disease and Dementia on March 29

At 2:30 p.m. on Thursday, March 29, St. Catherine’s Village will welcome Dr. Thomas Mosley to its Commons Activity Room for an hour-long educational seminar. While the program is free and open to the public, seating is limited so reservations…

Debra of America and PC Project Lead Patient-Focused Drug Development Meeting With FDA

Debra of America and PC Project Lead Patient-Focused Drug Development Meeting With FDA

The Dystrophic Epidermolysis Bullosa Research Association of America (Debra of America) and the Pachyonychia Congenita Project (PC Project) are pleased to announce a joint Externally-Led Patient-Focused Drug Development (EL-PFDD) meeting with the FDA on our respective rare diseases, pachyonychia congenita (PC) and epidermolysis…

New Xtalks Webinar to Address the Increasing Demand for Single-Site Pre-Market Approval Models in the Pursuit of Companion Diagnostic Development (CDx)

New Xtalks Webinar to Address the Increasing Demand for Single-Site Pre-Market Approval Models in the Pursuit of Companion Diagnostic Development (CDx)

Join esteemed speakers from Covance including Steven Anderson, PhD, Senior Vice President and Chief Scientific Officer, and Tom Turi, PhD, Vice President of Companion Diagnostics for a live session on Wednesday, March 21, 2018 at 11 a.m. EDT (3 p.m.…

Real World Evidence: A Data-Centric Approach to Efficiently and Securely Drive Value for the Future of Pharma, New Webinar Hosted by Xtalks

Real World Evidence: A Data-Centric Approach to Efficiently and Securely Drive Value for the Future of Pharma, New Webinar Hosted by Xtalks

Join the live broadcast of Xtalks' newest webinar, "Real World Evidence: A Data-Centric Approach to Efficiently and Securely Drive Value for the Future of Pharma," on Tuesday, March 20, 2018, at 11 a.m. EDT (3 p.m. GMT) as real world evidence (RWE) and market…

Shoulder, Wrist, Elbow and Foot & Ankle Replacement Market Gets a Huge Boost From Technology

Shoulder, Wrist, Elbow and Foot & Ankle Replacement Market Gets a Huge Boost From Technology

Growth in the market for minor orthopedic replacement implants has recently accelerated to 6.8 percent year on year, a report from The Business Research Company shows, so will be worth over $2 billion in 2021. All these minor joint replacements…

Polaryx Therapeutics Received Orphan Drug Designation From the European Medicines Agency (EMA) for the Treatment of Neuronal Ceroid Lipofuscinosis With PLX-200

Polaryx Therapeutics Received Orphan Drug Designation From the European Medicines Agency (EMA) for the Treatment of Neuronal Ceroid Lipofuscinosis With PLX-200

Polaryx Therapeutics, Inc. is a biotech company developing patient-friendly oral small molecule therapeutics for Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL) and other forms of NCL, commonly known as Batten disease. Neuronal Ceroid Lipofuscinosis qualifies as rare pediatric disease under Section…

New Molecular Test to Impact Influenza Pandemic Preparedness

New Molecular Test to Impact Influenza Pandemic Preparedness

InDevR Inc., a Boulder-based analytical technology and life science company, today announced plans to launch a Research Use Only (RUO) version of their FluChip-8G technology to aid in pandemic preparedness. The new molecular test addresses an unmet need for more detailed…

The CHEF1® Expression Technology Advantage for Accelerated Biologics Production, New Webinar Hosted by Xtalks

The CHEF1® Expression Technology Advantage for Accelerated Biologics Production, New Webinar Hosted by Xtalks

Biologics’ proprietary CHEF1® Expression System accelerates development of cell lines for cGMP biologics production. The innovative platform utilizes robust procedures and reliable raw materials, including chemically defined media, adapted Chinese hamster ovary (CHO) cells, and CHEF1 expression plasmids, to produce high…

Vaccine Development Strategies for Stubborn Diseases: Battling the Measles and Mumps Comeback, New Webinar Hosted by Xtalks

Vaccine Development Strategies for Stubborn Diseases: Battling the Measles and Mumps Comeback, New Webinar Hosted by Xtalks

This upcoming presentation will address the challenges vaccine developers need to overcome when designing programs for resurgent diseases such as measles and mumps. The live session takes place on Thursday, Feb. 15, 2018 at 10 a.m. EST (3 p.m. GMT)…

Let's Go Robotics Announces Precise Drop™ Micro-Dispensing Systems

Let's Go Robotics Announces Precise Drop™ Micro-Dispensing Systems

​Let’s Go Robotics today announced Precise Drop™ micro-dispensing systems. These systems are the latest innovation by the company for life sciences and medical diagnostics applications. Precise Drop is highly configurable, making it easy to use in any environment from benchtop…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login